E1L3N
Live / Registered — Registered and renewed (as of 31 Jul 2025)
What this means for you
Registered since 02 Sept 2014. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 02 Sept 2024).
Record
- Serial number
- 86254212
- Registration number
- 4597348
- Mark type
- Stylized text
- Filed
- 16 Apr 2014
- Published for opposition
- 17 Jun 2014
- Registered
- 02 Sept 2014
- Next maintenance due
- 02 Sept 2024
- Attorney of record
- Keith A. Weltsch, Esq.
Goods and services
- Class 001 — Chemicals: Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use
Owner
- Cell Signaling Technology, Inc., Danvers, MA, US
- Cell Signaling Technology, Inc., Danvers, MA, US
- Cell Signaling Technology, Inc., Danvers, MA, US
Prosecution history
- 31 Jul 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 31 Jul 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 31 Jul 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 06 Jun 2025 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 06 Dec 2024 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 06 Dec 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 Aug 2024 — TEAS SECTION 8 & 9 RECEIVED
- 02 Sept 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 08 Mar 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Mar 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Mar 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Jun 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 23 Jun 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 23 Jun 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Feb 2021 — TEAS SECTION 8 & 15 RECEIVED